Search results
Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML
Zacks via Yahoo Finance· 2 years agoThe CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic...
Novartis (NVS) Chronic Myeloid Leukemia Drug Approved by EC
Zacks via Yahoo Finance· 2 years agoNovartis NVS announced that the European Commission (EC) has approved Scemblix (asciminib) for the...
Terns Pharmaceuticals Inc (TERN) Reports Q3 2023 Financials and Corporate Progress
GuruFocus.com via Yahoo Finance· 5 months agoTERN-701 Phase 1 clinical trial for CML to commence with patient screening in December 2023....
What Are Myeloproliferative Neoplasms?
Health via Yahoo News· 1 month agoMedically reviewed by Archana Sharma, DO Myeloproliferative neoplasms (MPNs) are a group of blood cancers that occur when your bone marrow makes too many...
Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia
Benzinga via Yahoo Finance· 2 years agoThe European Commission (EC) has approved Novartis AG's (NYSE: NVS) Scemblix (asciminib) for adult...
What Is Acute Myeloid Leukemia?
Verywell Health via Yahoo News· 10 months agoA Rare and Aggressive Blood Cancer Md Babul Hosen / Getty Images Medically reviewed by Doru Paul, MD Acute myeloid leukemia (AML) is a rare blood cancer....
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
Zacks via Yahoo Finance· 2 years agoThis week, the FDA granted emergency approval to Pfizer PFE and partner BioNTech BNTX and Moderna’s...
Novartis: Scemblix approved in the EU for adults with chronic myeloid leukemia
Reuters via Yahoo News· 2 years agoZURICH (Reuters) - Novartis said on Monday its Scemblix was approved by the European Commission for...
Former Italy PM Berlusconi in intensive care with leukaemia, lung infection
Reuters via Yahoo News· 1 year agoMILAN (Reuters) -Former Italian Prime Minister Silvio Berlusconi has been suffering from chronic...
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Benzinga via Yahoo Finance· 2 weeks agoThursday, Enliven Therapeutics Inc (NASDAQ:ELVN) released proof of concept data from the Phase 1...